Zusammenfassung
Alte Menschen sind häufig von mehreren altersbedingten Beeinträchtigungen und Erkrankungen gleichzeitig betroffen (Multimorbidität), was die Untersuchung und das Verständnis der Verknüpfung zwischen der Alterung als dem entscheidenden Risikofaktor und einzelnen Syndromen schwierig macht. In einigen Kapiteln dieses Buchs wurden schon Verbindungen zwischen den molekularen Mechanismen der Alterung und der Pathogenese altersassoziierter Krankheiten aufgezeigt. Hier nun liegt der Fokus auf der Alzheimer‐Krankheit (AD, Alzheimer’s disease) und Krebs. Während Krebs mittlerweile in vielen Fällen pharmakologisch und/oder chirurgisch erfolgreich behandelt und manchmal sogar geheilt werden kann, ist AD noch immer eine unheilbare, tödlich verlaufende Erkrankung. Wie bei fast keiner anderen Krankheit ist das Auftreten von AD strikt mit dem Alter verknüpft und lässt einen starken Anstieg der Zahl der Krankheitsfälle für unsere alternde Gesellschaft erwarten. Die Autoren sind der Überzeugung, dass die eigentlichen Ursachen der Alzheimer‐Krankheit nur identifiziert werden können, wenn die Biochemie alternder Neuronen verstanden wird, speziell im Kontext bekannter Risikofaktoren.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Auber DFE (1997) Bloomsbury biographic dictionary of quotations. Bloomsbury, London
Ávalos Y, Canales J, Bravo-Sagua R, Criollo A, Lavandero S, Quest AF (2014) Tumor suppression and promotion by autophagy. Biomed Res Int 2014:603980
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer’s disease. Lancet 377(9770):1019–1031
Bartrés-Faz D, Arenaza-Urquijo EM (2011) Structural and functional imaging correlates of cognitive and brain reserve hypotheses in healthy and pathological aging. Brain Topogr 24(3-4):340–357
Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, Taylor RW, Turnbull DM (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38(5):515–517
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4):239–259
Burke SN, Barnes CA (2006) Neural plasticity in the ageing brain. Nat Rev Neurosci 7:30–40
Caserta MT, Bannon Y, Fernandez F, Giunta B, Schoenberg MR, Tan J (2009) Normal brain aging clinical, immunological, neuropsychological, and neuroimaging features. Int Rev Neurobiol 84:1–19
Clement AB, Gamerdinger M, Tamboli IY, Lütjohann D, Walter J, Greeve I, Gimpl G, Behl C (2009) Adaptation of neuronal cells to chronic oxidative stress is associated with altered cholesterol and sphingolipid homeostasis and lysosomal function. J Neurochem 111(3):669–682
Clement AB, Gimpl G, Behl C (2010) Oxidative stress resistance in hippocampal cells is associated with altered membrane fluidity and enhanced nonamyloidogenic cleavage of endogenous amyloid precursor protein. Free Radic Biol Med 48(9):1236–1241
Corbett A, Smith J, Ballard C (2012) New and emerging treatments for Alzheimer’s disease. Expert Rev Neurother 12(5):535–543
Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC (1992) Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 2:324–329
Crawford J, Cohen HJ (1987) Relationship of cancer and aging. Clin Geriatr Med 3(3):419–432
Crighton D, Wilkinson S, O’Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T, Ryan KM (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126(1):121–134
DeCarli C, Kawas C, Morrison JH, Reuter-Lorenz PA, Sperling RA, Wright CB (2012) Session II: Mechanisms of age-related cognitive change and targets for intervention: neural circuits, networks, and plasticity. J Gerontol A Biol Sci Med Sci 67(7):747–753
Erraji-Benchekroun L, Underwood MD, Arango V, Galfalvy H, Pavlidis P, Smyrniotopoulos P, Mann JJ, Sibille E (2005) Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry 57(5):549–558
Felzen V, Hiebel C, Koziollek-Drechsler I, Reißig S, Wolfrum U, Kögel D, Brandts C, Behl C, Morawe T (2015) Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function. Cell Death Dis 6:e1812
Finkel T, Serrano M, Blasco MA (2007) The common biology of cancer and ageing. Nature 448(7155):767–774
Fransen M, Nordgren M, Wang B, Apanasets O, Van Veldhoven PP (2013) Aging, age-related diseases and peroxisomes. Subcell Biochem 69:45–65
Galluzzi L, Pietrocola F, Bravo-San PJM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, Kimmelman A, Kumar S, Levine B, Maiuri MC, Martin SJ, Penninger J, Piacentini M, Rubinsztein DC, Simon HU, Simonsen A, Thorburn AM, Velasco G, Ryan KM, Kroemer G (2015) Autophagy in malignant transformation and cancer progression. EMBO J 34(7):856–880
Giannakopoulos P, Herrmann FR, Bussière T, Bouras C, Kövari E, Perl DP, Morrison JH, Gold G, Hof PR (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology. 60(9):1495–1500
Giuliani CM, Dass CR (2013) Autophagy and cancer: taking the ‘toxic’ out of cytotoxics. J Pharm Pharmacol 65(6):777–789
Gold G, Hof PR (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology 60:1495–1500
Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11(3):298–300
Jack CR Jr., Shiung MM, Gunter JL, O’Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC (2004) Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62:591–600
Jellinger KA, Attems J (2013) Neuropathological approaches to cerebral aging and neuroplasticity. Dialogues Clin Neurosci 15(1):29–43
Kandel ER (2001) The molecular biology of memory storage: a dialogue between genes and synapses. Science 294(5544):1030–1038
Kandel ER, Schwartz JH, Jessell TM, Siegelbaum SA, Hudspeth AJ (2012) Principles of Neural Science, 5. Aufl. McGraw-Hill Professional
Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR (2005) Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64:1152–1156
Kern A, Behl C (2009) The unsolved relationship of brain aging and late-onset Alzheimer disease. Biochim Biophys Acta 1790(10):1124–32
Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR, Investigators (2001) Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56:42–48
Lei Z, Brizzee C, Johnson GV (2015) BAG3 facilitates the clearance of endogenous tau in primary neurons. Neurobiol Aging 36(1):241–248
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153(6):1194–1217
Moosmann B, Behl C (2002) Antioxidants as treatment for neurodegenerative disorders. Expert Opin Investig Drugs 11(10):1407–1435
Niccoli T, Partridge L (2012) Ageing as a risk factor for disease. Curr Biol 22(17):R741–R752
Ohm TG, Müller H, Braak H, Bohl J (1995) Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer’s disease-related neurofibrillary changes. Neuroscience 64(1):209–217
Park DC, Bischof GN (2013) The aging mind: neuroplasticity in response to cognitive training. Dialogues Clin Neurosci 15(1):109–119
Pereira B, Ferreira MG (2013) Sowing the seeds of cancer: telomeres and age-associated tumorigenesis. Curr Opin Oncol 25(1):93–98
Pohanka M (2012) Acetylcholinesterase inhibitors: a patent review (2008 – present). Expert Opin Ther Pat 22(8):871–886
Price AR, Xu G, Siemienski ZB, Smithson LA, Borchelt DR, Golde TE, Felsenstein KM (2013) Comment on “ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models”. Science 340(6135):924-d
Rubinsztein DC, Mariño G, Kroemer G (2011) Autophagy and aging. Cell 146(5):682–95
Sastre M, Klockgether T, Heneka MT (2006) Contribution of inflammatory processes to Alzheimer’s disease: molecular mechanisms. Int J Dev Neurosci 24:167–176
Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002) Mapping the evolution of regional atrophy in Alzheimer’s disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci U S A 99:4703–4707
Schupf N, Tang MX, Fukuyama H, Manly J, Andrews H, Mehta P, Ravetch J, Mayeux R (2008) Peripheral Abeta subspecies as risk biomarkers of Alzheimer’s disease. Proc Natl Acad Sci U S A 105:14052–14057
Shen S, Kepp O, Kroemer G (2012) The end of autophagic cell death? Autophagy 8(1):1–3
Sibille E (2013) Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders. Dialogues Clin Neurosci 15(1):53–65
Stumm C, Hiebel C, Hanstein R, Purrio M, Nagel H, Conrad A, Lutz B, Behl C, Clement AB (2013) Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition. Neurobiol Aging 34(11):2574–2584
Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hänninen T, Soininen H, Kervinen K, Kesäniemi YA, Laakso M, Kuusisto J (2006) Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 67:843–847
Veeraraghavalu K, Zhang C, Miller S, Hefendehl JK, Rajapaksha TW, Ulrich J, Jucker M, Holtzman DM, Tanzi RE, Vassar R, Sisodia SS (2013) Comment on “ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Science 340(6135):924-f
Vehmas AK, Kawas CH, Stewart WF, Troncoso JC (2003) Immune reactive cells in senile plaques and cognitive decline in Alzheimer’s disease. Neurobiol Aging 24:321–331
Vessoni AT, Filippi-Chiela EC, Menck CF, Lenz G (2013) Autophagy and genomic integrity. Cell Death Differ 20(11):1444–1454
Vijg J, Suh Y (2013) Genome instability and aging. Annu Rev Physiol 75:645–668
Wagster MV (2009) Cognitive aging research: an exciting time for a maturing field: a postscript to the special issue of neuropsychology review. Neuropsychol Rev 19(4):523–525
Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64:277–281
Zhu Y, Carvey PM, Ling Z (2006) Age-related changes in glutathione and glutathione-related enzymes in rat brain. Brain Res 1090:35–44
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Behl, C., Ziegler, C. (2016). Ausgewählte altersbedingte Erkrankungen. In: Molekulare Mechanismen der Zellalterung und ihre Bedeutung für Alterserkrankungen des Menschen. Springer Spektrum, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48250-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-662-48250-6_4
Published:
Publisher Name: Springer Spektrum, Berlin, Heidelberg
Print ISBN: 978-3-662-48249-0
Online ISBN: 978-3-662-48250-6
eBook Packages: Life Science and Basic Disciplines (German Language)